Literature DB >> 25565763

Quality of life following glaucoma surgery: canaloplasty versus trabeculectomy.

Thomas Klink1, Johannes Sauer1, Norbert J Körber2, Franz Grehn1, Martin M Much1, Luisa Thederan1, Juliane Matlach1, Josefina Parente Salgado1.   

Abstract

PURPOSE: To evaluate quality of life (QoL) with a new questionnaire after canaloplasty (CP) and trabeculectomy (TE). PATIENTS AND METHODS: We assessed outcomes of surgery, rate of revision surgeries, patients' mood, and influence of postoperative care on QoL, surgery interference with daily activities, and postsurgical complaints. Patients completed the QoL questionnaire 24 months after surgery.
RESULTS: Patients who underwent CP (n=175) were compared to TE patients (n=152). In the CP group, 57% of patients expressed high satisfaction, while 41% of patients in the TE group said they were highly satisfied. The satisfaction difference was statistically significant (P=0.034). Significantly fewer second surgeries were needed after CP (8% CP versus 35% TE, P<0.001). Patients were more positive in the CP group (54% CP versus 37% TE, P<0.009). Stress related to postoperative care was lower in the CP group compared to the TE group (14% versus 46%). Difficulties with activities of daily living, such as reading, were much lower or even nonexistent after CP, and complaints like eye burning or stinging were significantly lower in the CP group.
CONCLUSIONS: Compared with TE, CP is associated with less QoL impairment and higher patient satisfaction after surgery. However, long-term data on intraocular pressure reduction after surgery are needed to confirm long-term patient satisfaction with this surgery.

Entities:  

Keywords:  glaucoma; glaucoma surgery; non-penetrating glaucoma surgery; postoperative care

Year:  2014        PMID: 25565763      PMCID: PMC4274143          DOI: 10.2147/OPTH.S72357

Source DB:  PubMed          Journal:  Clin Ophthalmol        ISSN: 1177-5467


Introduction

According to the guidelines of the European Glaucoma Society, “the goal of glaucoma treatment is to maintain the patient’s visual function and related quality of life (QoL), at a sustainable cost.”1 In medically uncontrolled chronic open angle glaucoma, the gold standard for reducing intraocular pressure is trabeculectomy (TE), a type of penetrating glaucoma surgery. Unfortunately, this is associated with severe intraoperative and postoperative complications, such as overfiltration with hypotony and further complications like wound leak, bleb scarring, revision surgery, and blebitis.2 A newer surgical procedure avoiding severe bleb-related complications is canaloplasty (CP), a nonpenetrating surgical method. The aims of this surgery are to restore the natural outflow pathways and to achieve blebless intraocular pressure control.3 The rate of complications is lower than with TE,4 but CP comprises surgery-specific complications such as detachment of Descemet’s membrane.5 Assessment of QoL and patient satisfaction is becoming increasingly important in the decision-making process regarding the choice of a therapeutic procedure. There are currently several ways to measure QoL. Some are very general in nature. Others have been developed specifically for ophthalmologic use (eg, the Visual Function Index6). With regard to glaucoma, there are some established questionnaires, eg, the Glaucoma Quality of Life–15 Items or the Glaucoma Symptom Scale,7,8 but none address glaucoma surgery-related issues. The aims of this study were to evaluate QoL and patient satisfaction after glaucoma surgery and to determine whether there were any differences between CP and TE. A new QoL questionnaire was developed specifically for this study.

Materials and methods

Patients

For this cross-sectional retrospective study, we consecutively selected patients with primary open angle glaucoma undergoing either trabeculectomy with mitomycin C or canaloplasty between 2008 and 2010. Phacotrabeculectomy and phacocanaloplasty was performed in 20.4% (31 of 121 trabeculectomy patients) and 35.8% (63 of 113 canaloplasty patients), respectively. The surgeries were carried out by one of three surgeons: NK, FG, or TK. The study was approved by University of Würzburg’s institutional review board, and all patients provided written informed consent.

QoL questionnaire

In order to assess the influence of surgery on daily activities, postoperative complaints, subjective outcomes of surgery, rate of revision surgeries, patients’ postoperative mood, and the influence of postoperative care on QoL, a questionnaire with different subscales was developed. We have used the following existing and established questionnaires8–16: Glaucoma Symptom Scale, Visual Activities Questionnaire, Impact of Vision Impairment, National Eye Institute–Visual Functioning Questionnaire, National Eye Institute–Visual Functioning Questionnaire–25 items, Glaucoma Health Perception Index, Glaucoma Quality of Life–15 items, Activities of Daily Vision Scale, and Visual Function Questionnaire–14 items. Additionally, surgery-specific questions developed by expert consensus (three glaucoma surgeons: NK, FG, and TK) were included. The QoL questionnaire (Supplementary material) was mailed to the patients 24 months after surgery. The aim of the QoL measures was to assess patients’ perceptions of their visual function, visually related complaints, nonvisual ophthalmic complaints, and overall topics related to surgery and daily life. The questionnaire included 21 items that are listed in Table 1.
Table 1

Questionnaire items

Item descriptionQuestionnaireSubscale
1. Change in visual acuityVisual ocular symptoms
2. Reading newspapersNEI-VFQ-25, VF-14, VAQ, IVI, NEI-VFQ, GQL-15, ADVS
3. Watching televisionNEI-VFQ-25, VF-14, IVI, NEI-VFQ, GQL-15, ADVS
4. Seeing at nightNEI-VFQ-25, VF-14, GSS, VAQ, GQL-15, ADVS
5. DrivingNEI-VFQ-25, VF-14, VAQ, NEI-VFQ, ADVS
6. GlareGSS, VAQ, GQL-15, ADVSNonvisual ocular symptoms
7. Burning and stinging of the eyeNEI-VFQ-25, GSS, NEI-VFQ
8. Foreign body sensationGSS
9. TearingGSS
10. Redness
11. DrynessGSS
12. Restriction of social contacts (attending social functions, meeting with friends)VFQ25, IVI, NEI-VFQ, GHPI, GQL-15Self-care and social life
13. Loss of independence (less control over own body, being a burden on others, loss of confidence in doing usual activities)NEI-VFQ-25, IVI, NEI-VFQ, GQL-15, ADVS
14. Postoperative moodEmotional symptoms
15. Stress caused by surgery
16. Stress caused by postoperative care
17. Difference in number of eye drops before/after surgeryResults of surgery
18. Difference in number of follow-ups before/after surgery
19. Number of revision surgeries
20. Fulfilling of expectations not to use drops anymorePatient satisfaction
21. Satisfaction with results of surgery

Notes: Items 1–13, 15, 16, and 20 were scored on a five-level scale: 5 = not at all, 4 = slightly, 3 = partially, 2 = predominantly, 1 = extremely, 0 = not rated. Item 14: Select two terms from a list of words associated with a negative meaning (eg, frustrated, helpless), a neutral meaning (eg, uncertain), or a positive meaning (eg, happy, carefree). Items 17 and 18 were scored on a three-level scale: 1 = more, 2 = equal, or 3 = less. Item 19: Number of revision surgeries after the initial procedure (zero, once, twice, three times, four times or more than four times. Item 21 had ten levels, from 0 = totally discontent up to 10 = totally content.

Abbreviations: ADVS, Activities of Daily Vision Scale; GHPI, Glaucoma Health Perception Index; GQL-15, The Glaucoma Quality of Life–15 items; GSS, Glaucoma Symptom Scale; IVI, Impact of Vision Impairment; NEI-VFQ, National Eye Institute–Visual Functioning Questionnaire; NEI-NEI-NEI-VFQ-25, National Eye Institute–Visual Functioning Questionnaire–25 items; VAQ, Visual Activities Questionnaire; VF-14, Visual Function Questionnaire–14 items.

The first 13 items and items 15, 16, and 20 of Table 1 were scored on a five-level scale to report how surgery had interfered with the different activities and emotions. Scores were assigned as follows: 5 = not at all, 4 = slightly, 3 = partially, 2 = predominantly, and 1 = extremely. A score of 0 was assigned if the patient was not able to rate the activity. For item 14, patients could select two terms from a list of words associated with a negative meaning (eg, frustrated, helpless), a neutral meaning (eg, uncertain) or a positive meaning (eg, happy, carefree). Items 17 and 18 were scored on a three-level scale: 1 = more, 2 = equal, or 3 = less. Item 19 asked about the number of revision surgeries a patient required after the initial procedure. Patients were given ordinal options: zero, once, twice, three times, four times, or more than four times. Item 21 had ten levels, from 0 = totally discontent up to 10 = totally content.

Statistical analysis

The data were analyzed with SPSS statistical software (version 16.0; SPSS Inc., Chicago, IL, USA). To compare the two treatment groups, Student’s t-test and Pearson’s chi-square test were performed after averaging the scores. Where appropriate, values are given as means ± standard deviation. Statistical significance was considered to be P≤0.05.

Results

The questionnaire was sent to 423 patients (212 CP and 211 TE patients). A total of 327 patients returned the completed questionnaire (return rate of 75.8%). Of the 327 questionnaires, 175 were completed by CP patients and 152 by TE patients. This represents a balanced evaluation result, with 53.7% and 46.3% questionnaires being completed by CP and TE patients, respectively. Patients were aged 18–90 years (46.6% men, 53.4% women), with the 175 patients in the CP group consisting of 91 men and 84 women (aged 69.5±10.2 years) and the 152 patients in the TE with mitomycin C group consisting of 62 men and 90 women (aged 66.7±11.8 years). Overall, canaloplasty patients had a higher QoL regarding positive postoperative mood, satisfaction with results of surgery, and lower rates of visual and nonvisual symptoms and stress caused by surgery or postsurgical treatment. No difference between trabeculectomy and canaloplasty was seen for restriction from social contacts and loss of independence. The evaluation of visual ocular symptoms, such as change in visual acuity, reading newspapers, watching television, seeing in the dark, and driving were all significantly different in the two groups and were rated better in the canaloplasty group. Surgery interference with daily activities, eg, impairment in reading, was rated as much lower to nonexistent in the CP group (Figure 1). Likewise, there were differences in the nonvisual ocular symptoms, with significantly lower ratings of glare, burning and stinging of the eye, foreign body sensation, tearing, redness, and dryness in the CP group compared with the TE group (Figure 2). Further significant differences were observed in patients’ mood (positive mood: 54% in the CP group versus 37% in the TE group, P=0.009) and the stress caused by surgery, with patients in the CP group being happier and less stressed about the surgery (84% versus 51% in the TE group, P<0.001). The stress induced by the postsurgical care was also significantly lower after CP (14% versus 46% in the TE group, P<0.001). In contrast, the differences in the number of follow-ups before and after surgery were comparable between the groups. Fifty-seven percent of the patients undergoing CP were highly satisfied with the results of surgery; in the TE group, this rate was 41%. Interestingly, the other side of the scale, which depicted patients who were not at all satisfied with the surgery, revealed 6% in the CP group and 3% in TE group. The significant differences in patient satisfaction are shown in Figure 3 (mean ± standard deviation =8.09±2.71 in the CP group and 7.46±2.61 in the TE group; P=0.034). The rate of revision surgeries was significantly lower after CP (8% versus 35% after TE; P<0.001).
Figure 1

Quality-of-life-questionnaire: visual ocular symptoms.

Notes: Change in reading, watching TV, driving, and seeing at night were scored on a five-level scale: 5 = not at all, 4 = slightly, 3 = partially, 2 = predominantly, 1 = extremely, 0 = not rated. A higher score defines few to no visual symptoms. Values are means and error bars indicate the standard deviation.

Abbreviations: CP, canaloplasty; TE, trabeculectomy; TV, television.

Figure 2

Quality-of-life-questionnaire: nonvisual ocular symptoms.

Notes: Glare, burning and stinging of the eye, foreign body sensation, dryness of the eye, and redness of the eye were scored on a five-level scale: 5 = not at all, 4 = slightly, 3 = partially, 2 = predominantly, 1 = extremely, 0= not rated. A higher score defines few to no nonvisual symptoms. Values are means and error bars indicate the standard deviation.

Abbreviations: CP, canaloplasty; TE, trabeculectomy.

Figure 3

Quality-of-life-questionnaire: patient satisfaction with the results of surgery.

Notes: Satisfaction with the surgery was scored from 0 = totally discontent up to 10 = totally content. A higher score defines a better overall satisfaction with the results of the surgery. Values are means and error bars indicate the standard deviation.

Abbreviations: CP, canaloplasty; TE, trabeculectomy.

Social functions, such as the restriction from social contacts, did not show significant differences between groups (P=0.766). The two treatment groups were also comparable for the perception of loss of independence (P=0.875), the expectation not to use drops anymore (P=0.631), and the difference in number of eye drops before and after surgery. The full results are summarized in Table 2.
Table 2

Quality of life outcomes

Canaloplasty
Trabeculectomy
P-value*
nMean ± SDnMean ± SD
Change in visual acuity1103.29±0.821122.83±0.940.001
Reading newspapers1084.27±1.081183.65±1.15<0.001
Watching television1094.37±0.921173.79±1.11<0.001
Seeing at night1084.31±0.981193.82±1.10<0.001
Driving944.28±1.06963.56±1.20<0.001
Glare1104.02±1.091203.36±1.31<0.001
Pain1124.33±0.841183.86±1.15<0.001
Foreign body sensation1764.08±1.081523.78±1.180.016
Tearing1764.28±0.851524.04±1.050.024
Redness1713.85±0.981503.47±1.210.003
Dry eye1704.09±0.951513.44±1.20<0.001
Fulfillment of expectations not to use drops anymore1134.09±1.361164.00±1.430.6
Stress caused by surgery1754.18±0.861493.59±1.12<0.001
Stress caused by follow-ups/treatments1764.36±0.801513.40±1.20<0.001
Difference in number of eye drops before/after surgery1132.76±0.511182.73±0.560.7
Difference in number of follow-ups before/after surgery1744.36±0.801513.40±1.200.2
Revision surgeries1760.12±0.431500.67±1.14<0.001
Postoperative mood1762.30±0.831511.96±0.870.009
Satisfaction with results of surgery1758.09±2.711527.46±2.610.034
Restriction of social contacts1104.54±0.991154.57±0.900.8
Loss of independence1124.45±0.881214.45±0.880.9

Notes:

Student’s t-test, Pearson’s chi-square test as appropriate.

Abbreviations: n, number of answers; SD, standard deviation.

Discussion

The goals of glaucoma surgery are not only to reduce intraocular pressure, but also especially to maintain visual fields and visual acuity, preserving the patient’s QoL and independence. It also aims to improve QoL, for example, by reducing the interference from the disease with daily life and by decreasing ophthalmic therapy along with associated ocular and systemic side effects and complications. There are a few published studies evaluating QoL in glaucoma,8–16 but none have compared CP with TE. This study evaluated the QoL of patients after glaucoma surgery. Visually-related criteria were used, as found in the Glaucoma Quality of Life–15 items questionnaire.14 A significant difference was found in central vision activities, with CP showing less interference with those than TE. This might be explained by the postoperative complications of TE, such as hypotony, which are associated with a reduction in central vision. Nonvisual ocular symptoms were also considered, as in the Glaucoma Symptom Scale.8 Likewise, we found a significant difference between the CP and TE groups in the subscale of nonvisual symptoms, with better QoL in the CP group. The nonvisual ocular symptoms expressed mostly by patients in the TE group are probably related to the postoperative subconjunctival use of antiproliferative substances, such as 5-fluorouracil. Follow-up visits and postoperative treatments are more common and extensive after TE, which might cause more discontent and stress. In this study, the stress caused by surgery, as well as by treatments and follow-up visits, was significantly higher in the TE group, a finding that is supported by a lower satisfaction rating in this group (41% highly satisfied after TE versus 57% after CP). Surprisingly, the analysis of the number of follow-ups before and after surgery revealed no significant difference between the two groups: 14.5% of patients in the TE group had to visit the ophthalmologist more often, compared with 7.5% in the CP group. This is in agreement with the data published by Taube et al18 regarding the number of postoperative visits and bleb revisions after TE. A study by Ayyala et al4 showed no statistical difference when comparing the number of revision surgeries with CP and TE. In our cohort, the number of revision surgeries was significantly higher in the TE group. This result supports the known higher complication rate of TE and the greater need for revision surgeries in penetrating glaucoma surgery, as well as the findings of Lewis et al5 with a rare re-intervention after CP. Activities of daily living and psychological aspects (individual experiences, emotions, and behavior), as used in the Glau-QoL 36-item questionnaire17 and in Jampel’s Glaucoma Health Perception Indices,19 were also evaluated. There were no significant differences between the CP and TE groups for restriction of social contacts, self-esteem, or loss of independence. However, the postoperative mood was significantly better in the CP group, which may be related to a less-intensive need for postoperative care and revision procedures. Overall, our study showed good results for maintenance of QoL after glaucoma surgery, with patients expressing high satisfaction with the outcomes of surgery both after CP and TE. A slight superiority of CP was noted, with a significantly higher satisfaction rate in the CP group. On the other hand, it should be pointed out that the percentage of completely unsatisfied patients was greater in the CP group than in the TE group. This fact may be related to greater expectations or to insufficient intraocular pressure reduction in this group. Limitations of our study are its retrospective design, a common source of bias and confounding. We have focused only on QoL assessment following canaloplasty or trabeculectomy. Therefore, patients were not compared regarding severity of glaucoma, including preoperative intraocular pressure, visual acuity, number of medications, and previous ocular surgeries. Prospective long-term studies with a greater sample size and patients with comparable preoperative characteristics are needed to confirm these results. In summary, our findings indicate that CP is associated with an overall lower impairment of QoL after surgery and with higher patient satisfaction than TE. Long-term data on intraocular pressure reduction after surgery are needed to confirm long-term patient satisfaction and cost efficiency with this new type of nonpenetrating surgery.

Supplementary material

Quality of life questionnaire: trabeculectomy versus canaloplasty

Question 1: Have you had a combined cataract and glaucoma surgery (trabeculectomy or canaloplasty)? ○ Yes ○ No Question 2: Has your vision changed after surgery? ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Question 3: How long did you stay in the hospital after surgery? outpatient (6) ○ up to 3 days (5) ○ up to 5 days (4) ○ up to 7 days (3) ○ up to 14 days (2) ○ more than 14 days (1) Question 4: How has the surgery influenced the following daily activities? Reading a newspaper/book ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Watching TV ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Seeing at night ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Driving ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Question 5: Have you suffered from glare after surgery? ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Question 6: Have you suffered from burning and stinging of the eye after surgery? ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Question 7: Have you suffered from a foreign body sensation after surgery? ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Question 8: Have you suffered from tearing after surgery? ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Question 9: Have you suffered from a red eye after surgery? ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Question 10: Have you suffered from a dry eye after surgery? ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Question 11: How were your expectation fulfilled not to use eye drops after surgery? ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Question 12: Do you take ○ more (1) ○ same (2) ○ less (3) eye drops after surgery? Question 13: How stressful was the surgery for you? ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Question 14: How stressful were the follow-up appointments and treatments after surgery? ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Question 15: Have you had a second, third etc. surgery after the initial trabeculectomy or canaloplasty? If yes, how many ○ No (6) ○ one (5) ○ two (4) ○ three (3) ○ four (2) ○ more than four (1) Question 16: Has your social life (eg, going out with friends) changed after surgery? ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Question 17: Were you less independent (less control over own body, being a burden on others, loss of confidence in doing usual activities) after surgery? ○ not at all (5) ○ slightly (4) ○ partially (3) ○ predominantly (2) ○ extremely (1) ○ not rated (0) Question 18: Number of follow-up appointments after surgery ○ less often (3) ○ same (2) ○ more often (1) than before surgery. Question 19: How satisfied were you with the results of the surgery? Scale = 0 (totally discontent) to 10 (totally content 0____________________________________________10 Question 20: How is your mood after surgery? (not more than 2 words) frustrated – annoyed – anxious – helpless – worried – doubtful satisfied – happy – cheerful – worry-free – glad – confident Question 21: How old are you? ___ When did you have the surgery (month/year)? _______ Are you ○ female ○ male Thank you very much!
  17 in total

Review 1.  The changing conceptual basis of trabeculectomy: a review of past and current surgical techniques.

Authors:  M Reza Razeghinejad; Scott J Fudemberg; George L Spaeth
Journal:  Surv Ophthalmol       Date:  2012 Jan-Feb       Impact factor: 6.048

2.  [Non-penetrating glaucoma surgery].

Authors:  Michael Niegel; Norbert Körber
Journal:  Klin Monbl Augenheilkd       Date:  2012-04-11       Impact factor: 0.700

3.  Development of the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  C M Mangione; P P Lee; P R Gutierrez; K Spritzer; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  2001-07

4.  Quality of life in newly diagnosed glaucoma patients : The Collaborative Initial Glaucoma Treatment Study.

Authors:  N K Janz; P A Wren; P R Lichter; D C Musch; B W Gillespie; K E Guire
Journal:  Ophthalmology       Date:  2001-05       Impact factor: 12.079

5.  Canaloplasty: Three-year results of circumferential viscodilation and tensioning of Schlemm canal using a microcatheter to treat open-angle glaucoma.

Authors:  Richard A Lewis; Kurt von Wolff; Manfred Tetz; Norbert Koerber; John R Kearney; Bradford J Shingleton; Thomas W Samuelson
Journal:  J Cataract Refract Surg       Date:  2011-04       Impact factor: 3.351

6.  The VF-14. An index of functional impairment in patients with cataract.

Authors:  E P Steinberg; J M Tielsch; O D Schein; J C Javitt; P Sharkey; S D Cassard; M W Legro; M Diener-West; E B Bass; A M Damiano
Journal:  Arch Ophthalmol       Date:  1994-05

Review 7.  Disparities between ophthalmologists and their patients in estimating quality of life.

Authors:  Joshua D Stein
Journal:  Curr Opin Ophthalmol       Date:  2004-06       Impact factor: 3.761

8.  Measurement of health-related quality of life with glaucoma: validation of the Glau-QoL 36-item questionnaire.

Authors:  Alain Béchetoille; Benoit Arnould; Alain Bron; Christophe Baudouin; Jean-Paul Renard; Eric Sellem; Yves Brouquet; Philippe Denis; Jean-Philippe Nordmann; Marie-Claude Rigeade; Ana Bassols; Khadra Benmedjahed; Isabelle Guillemin; Jean-François Rouland
Journal:  Acta Ophthalmol       Date:  2007-08-28       Impact factor: 3.761

9.  Development of the 'Activities of Daily Vision Scale'. A measure of visual functional status.

Authors:  C M Mangione; R S Phillips; J M Seddon; M G Lawrence; E F Cook; R Dailey; L Goldman
Journal:  Med Care       Date:  1992-12       Impact factor: 2.983

10.  Depression and mood indicators in newly diagnosed glaucoma patients.

Authors:  Henry D Jampel; Kevin D Frick; Nancy K Janz; Patricia A Wren; David C Musch; Rajiv Rimal; Paul R Lichter
Journal:  Am J Ophthalmol       Date:  2007-06-11       Impact factor: 5.258

View more
  20 in total

1.  A modified scleral dissection technique with suprachoroidal drainage for canaloplasty.

Authors:  Peter Szurman; Kai Januschowski; Karl Thomas Boden; Gesine Bettina Szurman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-14       Impact factor: 3.117

2.  Comparison of canaloplasty and trabeculectomy for open angle glaucoma: a Meta-analysis.

Authors:  Zhong-Jing Lin; Shuo Xu; Shou-Yue Huang; Xiao-Bin Zhang; Yi-Sheng Zhong
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

3.  Suprachoroidal drainage with collagen sheet implant- a novel technique for non-penetrating glaucoma surgery.

Authors:  Peter Szurman; Kai Januschowski; Karl Thomas Boden; Anna-Maria Seuthe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-12-19       Impact factor: 3.117

Review 4.  Progression on canaloplasty for primary open angle glaucoma.

Authors:  Jun Zhang; Ning-Li Wang
Journal:  Int J Ophthalmol       Date:  2019-10-18       Impact factor: 1.779

5.  Is there a change in the quality of life comparing the micro-invasive glaucoma surgery (MIGS) and the filtration technique trabeculectomy in glaucoma patients?

Authors:  Milena Pahlitzsch; Matthias K J Klamann; Marie-Luise Pahlitzsch; Johannes Gonnermann; Necip Torun; Eckart Bertelmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-11-15       Impact factor: 3.117

Review 6.  [Modifications of canaloplasty : Strong pressure-lowering effect with a low risk profile].

Authors:  Peter Szurman; Karsten Klabe
Journal:  Ophthalmologie       Date:  2022-05-31

Review 7.  [Why trabeculectomy is better than its reputation].

Authors:  Alicja Strzalkowska; Thomas Dietlein; Carl Erb; Esther M Hoffmann
Journal:  Ophthalmologie       Date:  2022-09-08

8.  Glaucoma Medication and Quality of Life after Phacoemulsification Combined with a Xen Gel Stent.

Authors:  Christian Pahljina; Stephanie Sarny; Lukas Hoeflechner; Thomas Falb; Gernot Schliessleder; Marlene Lindner; Domagoj Ivastinovic; Kaweh Mansouri; Ewald Lindner
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

9.  Patient experiences in retinal trials: a cross-sectional study.

Authors:  Cheryl Pui-Yan Au; Nicole Fardell; Maria Williams; Samantha Fraser-Bell; Anna Campain; Mark Gillies
Journal:  BMC Ophthalmol       Date:  2015-07-23       Impact factor: 2.209

Review 10.  Canaloplasty: Current Value in the Management of Glaucoma.

Authors:  Carlo Cagini; Claudia Peruzzi; Tito Fiore; Leopoldo Spadea; Myrta Lippera; Stefano Lippera
Journal:  J Ophthalmol       Date:  2016-04-30       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.